CorMedix IncNASDAQ:CRMD
- LAST PRICE10.3300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots10.0100/ 3
- Ask / Lots10.7700/ 5
- Open / Previous Close--- / 10.3300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 12270 | 10.73 |
| 09:33 ET | 2341 | 10.65 |
| 09:35 ET | 200 | 10.6435 |
| 09:37 ET | 1360 | 10.5984 |
| 09:39 ET | 4550 | 10.58 |
| 09:42 ET | 805 | 10.54 |
| 09:44 ET | 2133 | 10.62 |
| 09:46 ET | 1616 | 10.6001 |
| 09:48 ET | 3241 | 10.65 |
| 09:50 ET | 100 | 10.655 |
| 09:51 ET | 3015 | 10.66 |
| 09:53 ET | 617 | 10.64 |
| 09:55 ET | 4900 | 10.58 |
| 09:57 ET | 1400 | 10.63 |
| 10:00 ET | 4400 | 10.61 |
| 10:02 ET | 1751 | 10.57 |
| 10:04 ET | 21289 | 10.49 |
| 10:06 ET | 14497 | 10.47 |
| 10:08 ET | 935 | 10.45 |
| 10:09 ET | 1950 | 10.4801 |
| 10:11 ET | 11620 | 10.405 |
| 10:13 ET | 1205 | 10.39 |
| 10:15 ET | 2624 | 10.4342 |
| 10:18 ET | 3200 | 10.47 |
| 10:20 ET | 1500 | 10.49 |
| 10:22 ET | 1102 | 10.49 |
| 10:24 ET | 500 | 10.49 |
| 10:26 ET | 180 | 10.485 |
| 10:27 ET | 943 | 10.45 |
| 10:29 ET | 14341 | 10.35 |
| 10:31 ET | 3100 | 10.345 |
| 10:33 ET | 1570 | 10.34 |
| 10:36 ET | 1774 | 10.381 |
| 10:38 ET | 1100 | 10.42 |
| 10:40 ET | 500 | 10.41 |
| 10:42 ET | 5401 | 10.365 |
| 10:44 ET | 7659 | 10.44 |
| 10:45 ET | 5200 | 10.4435 |
| 10:47 ET | 600 | 10.45 |
| 10:49 ET | 869 | 10.48 |
| 10:51 ET | 1981 | 10.496 |
| 10:54 ET | 700 | 10.515 |
| 10:56 ET | 600 | 10.515 |
| 10:58 ET | 500 | 10.515 |
| 11:00 ET | 2850 | 10.5184 |
| 11:02 ET | 5954 | 10.52 |
| 11:03 ET | 3975 | 10.51 |
| 11:05 ET | 1982 | 10.5151 |
| 11:07 ET | 5348 | 10.51 |
| 11:09 ET | 1187 | 10.5 |
| 11:12 ET | 860 | 10.5 |
| 11:14 ET | 920 | 10.545 |
| 11:16 ET | 1650 | 10.57 |
| 11:18 ET | 2535 | 10.58 |
| 11:20 ET | 800 | 10.59 |
| 11:21 ET | 900 | 10.595 |
| 11:23 ET | 767 | 10.57 |
| 11:25 ET | 1292 | 10.575 |
| 11:27 ET | 1500 | 10.58 |
| 11:32 ET | 897 | 10.59 |
| 11:34 ET | 200 | 10.59 |
| 11:36 ET | 4533 | 10.585 |
| 11:38 ET | 1352 | 10.555 |
| 11:39 ET | 2823 | 10.5605 |
| 11:41 ET | 320 | 10.59 |
| 11:43 ET | 519 | 10.6 |
| 11:45 ET | 200 | 10.595 |
| 11:48 ET | 1390 | 10.58 |
| 11:50 ET | 885 | 10.565 |
| 11:52 ET | 200 | 10.56 |
| 11:54 ET | 2200 | 10.56 |
| 11:56 ET | 3293 | 10.588 |
| 11:57 ET | 5400 | 10.63 |
| 11:59 ET | 2400 | 10.6589 |
| 12:01 ET | 700 | 10.68 |
| 12:03 ET | 2560 | 10.695 |
| 12:06 ET | 4138 | 10.68 |
| 12:08 ET | 400 | 10.67 |
| 12:10 ET | 3500 | 10.68 |
| 12:12 ET | 3165 | 10.73 |
| 12:14 ET | 100 | 10.73 |
| 12:15 ET | 1850 | 10.7277 |
| 12:17 ET | 1090 | 10.7158 |
| 12:19 ET | 200 | 10.72 |
| 12:21 ET | 4200 | 10.73 |
| 12:24 ET | 2025 | 10.71 |
| 12:26 ET | 706 | 10.6998 |
| 12:28 ET | 644 | 10.69 |
| 12:30 ET | 3380 | 10.69 |
| 12:32 ET | 564 | 10.7 |
| 12:33 ET | 2276 | 10.705 |
| 12:35 ET | 100 | 10.695 |
| 12:37 ET | 756 | 10.67 |
| 12:39 ET | 3345 | 10.67 |
| 12:42 ET | 300 | 10.67 |
| 12:44 ET | 4042 | 10.7 |
| 12:46 ET | 300 | 10.705 |
| 12:48 ET | 1713 | 10.7 |
| 12:50 ET | 200 | 10.67 |
| 12:53 ET | 460 | 10.65 |
| 12:57 ET | 7100 | 10.675 |
| 01:00 ET | 700 | 10.65 |
| 01:02 ET | 200 | 10.64 |
| 01:04 ET | 1307 | 10.64 |
| 01:06 ET | 600 | 10.64 |
| 01:08 ET | 690 | 10.58 |
| 01:09 ET | 300 | 10.55 |
| 01:11 ET | 850 | 10.5559 |
| 01:13 ET | 3939 | 10.54 |
| 01:15 ET | 3000 | 10.5104 |
| 01:18 ET | 4699 | 10.5 |
| 01:20 ET | 3539 | 10.4838 |
| 01:22 ET | 2040 | 10.48 |
| 01:24 ET | 2000 | 10.52 |
| 01:26 ET | 2022 | 10.54 |
| 01:27 ET | 300 | 10.53 |
| 01:29 ET | 1526 | 10.52 |
| 01:31 ET | 800 | 10.5462 |
| 01:33 ET | 1201 | 10.53 |
| 01:36 ET | 300 | 10.51 |
| 01:38 ET | 500 | 10.52 |
| 01:40 ET | 4100 | 10.46 |
| 01:42 ET | 2590 | 10.42 |
| 01:44 ET | 2219 | 10.42 |
| 01:45 ET | 6986 | 10.42 |
| 01:47 ET | 3815 | 10.3808 |
| 01:49 ET | 5652 | 10.3867 |
| 01:51 ET | 100 | 10.385 |
| 01:54 ET | 2425 | 10.38 |
| 01:56 ET | 1950 | 10.3517 |
| 01:58 ET | 7760 | 10.37 |
| 02:00 ET | 2800 | 10.39 |
| 02:02 ET | 900 | 10.39 |
| 02:03 ET | 100 | 10.39 |
| 02:05 ET | 100 | 10.39 |
| 02:07 ET | 2000 | 10.39 |
| 02:09 ET | 2600 | 10.39 |
| 02:12 ET | 4435 | 10.35 |
| 02:14 ET | 1554 | 10.33 |
| 02:16 ET | 4024 | 10.33 |
| 02:18 ET | 2500 | 10.34 |
| 02:20 ET | 4402 | 10.32 |
| 02:21 ET | 1000 | 10.33 |
| 02:23 ET | 4200 | 10.37 |
| 02:25 ET | 700 | 10.41 |
| 02:27 ET | 3800 | 10.435 |
| 02:30 ET | 225 | 10.43 |
| 02:32 ET | 2960 | 10.42 |
| 02:34 ET | 5634 | 10.46 |
| 02:36 ET | 220 | 10.45 |
| 02:38 ET | 100 | 10.44 |
| 02:39 ET | 200 | 10.46 |
| 02:41 ET | 1067 | 10.46 |
| 02:43 ET | 2600 | 10.4502 |
| 02:45 ET | 3649 | 10.43 |
| 02:48 ET | 900 | 10.45 |
| 02:50 ET | 2299 | 10.42 |
| 02:54 ET | 2030 | 10.4 |
| 02:56 ET | 700 | 10.41 |
| 02:57 ET | 899 | 10.42 |
| 02:59 ET | 1640 | 10.39 |
| 03:01 ET | 2447 | 10.39 |
| 03:03 ET | 200 | 10.395 |
| 03:06 ET | 350 | 10.39 |
| 03:08 ET | 2462 | 10.435 |
| 03:10 ET | 900 | 10.44 |
| 03:12 ET | 500 | 10.44 |
| 03:14 ET | 1600 | 10.45 |
| 03:15 ET | 600 | 10.445 |
| 03:17 ET | 2202 | 10.47 |
| 03:19 ET | 2900 | 10.4899 |
| 03:21 ET | 1416 | 10.48 |
| 03:24 ET | 1920 | 10.49 |
| 03:26 ET | 313 | 10.48 |
| 03:28 ET | 1070 | 10.47 |
| 03:30 ET | 300 | 10.465 |
| 03:32 ET | 1403 | 10.43 |
| 03:33 ET | 650 | 10.43 |
| 03:35 ET | 2408 | 10.39 |
| 03:37 ET | 7407 | 10.38 |
| 03:39 ET | 4827 | 10.39 |
| 03:42 ET | 7494 | 10.42 |
| 03:44 ET | 700 | 10.42 |
| 03:46 ET | 6350 | 10.37 |
| 03:48 ET | 2361 | 10.41 |
| 03:50 ET | 2486 | 10.395 |
| 03:51 ET | 2577 | 10.39 |
| 03:53 ET | 4825 | 10.4 |
| 03:55 ET | 2759 | 10.4 |
| 03:57 ET | 20320 | 10.37 |
| 04:00 ET | 73235 | 10.33 |
Nov 4, 2024
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
8:30AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:56AM ET on Wednesday Oct 30, 2024 by Dow JonesCorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones*DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 626.8M | -12.9x | --- |
Zevra Therapeutics Inc | 487.3M | -4.7x | --- |
Elite Pharmaceuticals Inc | 659.9M | -105.6x | --- |
Cipla Ltd | 14.0B | 0.0x | --- |
Eton Pharmaceuticals Inc | 277.7M | -50.4x | --- |
Incannex Healthcare Inc | 34.8M | -1.4x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Chief Clinical Strategy and Operations Officer
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Legal Officer and Corporate Secretary
- Beth Kaufman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $626.8M |
|---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 60.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.57 |
EPS | $-0.80 |
Book Value | $1.28 |
P/E Ratio | -12.9x |
Price/Sales (TTM) | 51.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -415.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
